Viracta Therapeutics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Viracta Therapeutics (VIRX) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Viracta Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Viracta Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv

Quarterly reported holdings in Viracta Therapeutics by Goldman Sachs Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $6.3k | 27k | 0.23 |
2022-06-30 | $792k | 204k | 3.88 |
2022-03-31 | $717k | 151k | 4.76 |
2021-12-31 | $702k | 192k | 3.65 |
2021-09-30 | $1.4M | 171k | 8.02 |
2021-03-31 | $5.6M | 604k | 9.25 |